Repro-Med Systems, Inc. Forecast, price target & analysts
Repro-Med Systems, Inc. Target price 2025 - Analyst rating & recommendation
Repro-Med Systems, Inc. Classifications & Recommendation:
Repro-Med Systems, Inc. Price Target
| Target Price | $5.70 |
| Price | $3.43 |
| Potential |
66.18%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Repro-Med Systems, Inc. 2026 .
The average Repro-Med Systems, Inc. target price is $5.70.
This is
66.18%
register free of charge
$7.00
104.08%
register free of charge
$4.50
31.20%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Repro-Med Systems, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Repro-Med Systems, Inc. stock has an average upside potential 2026 of
66.18%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 28.52 | 33.70 |
| 2.22% | 18.15% | |
| EBITDA Margin | -32.96% | -9.76% |
| 9.76% | 70.39% | |
| Net Margin | -48.22% | -17.69% |
| 54.46% | 63.31% |
5 Analysts have issued a sales forecast Repro-Med Systems, Inc. 2024 . The average Repro-Med Systems, Inc. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Repro-Med Systems, Inc. EBITDA forecast 2024. The average Repro-Med Systems, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Repro-Med Systems, Inc. Analysts have issued a net profit forecast 2024. The average Repro-Med Systems, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.30 | -0.13 |
| 57.89% | 56.67% | |
| P/E | negative | |
| EV/Sales | 4.53 |
5 Analysts have issued a Repro-Med Systems, Inc. forecast for earnings per share. The average Repro-Med Systems, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Repro-Med Systems, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Repro-Med Systems, Inc....
Current Repro-Med Systems, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler | Locked ➜ Locked | Locked | Feb 14 2025 |
| Craig-Hallum | Locked ➜ Locked | Locked | Jan 17 2025 |
| Lake Street | Locked ➜ Locked | Locked | Jan 14 2025 |
| Canaccord Genuity | Locked ➜ Locked | Locked | Nov 14 2024 |
| Craig-Hallum | Locked ➜ Locked | Locked | Nov 14 2024 |
| Piper Sandler | Locked ➜ Locked | Locked | Nov 14 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler: Locked ➜ Locked
|
Feb 14 2025 |
|
Locked
Craig-Hallum: Locked ➜ Locked
|
Jan 17 2025 |
|
Locked
Lake Street: Locked ➜ Locked
|
Jan 14 2025 |
|
Locked
Canaccord Genuity: Locked ➜ Locked
|
Nov 14 2024 |
|
Locked
Craig-Hallum: Locked ➜ Locked
|
Nov 14 2024 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Nov 14 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
